Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal tumors

H C Ruckle1, V E Torres, R L Richardson

  • 1Department of Urology, Mayo Clinic, Rochester, MN 55905.

Current Opinion in Nephrology and Hypertension
|March 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adoption of a Urologic Oncology Perioperative Surgical Home is Associated with Decreased Total Length of Stay: A Pilot Study.

Urology practice·2023
Same author

Carcinoma in Situ of the Bladder.

Cancer·2018
Same author

Impact of NADiA ProsVue PSA slope on secondary treatment decisions after radical prostatectomy.

Prostate cancer and prostatic diseases·2014
Same author

Robotic-assisted surgery and the evolution of the radical prostatectomy.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology·2012
Same author

Bilateral renal-cell cancer treated surgically is associated with favorable disease outcome.

International journal of oncology·2011
Same author

Urothelial carcinoma of the bladder with choriocarcinomatous differentiation A report of two cases and review of the literature.

Urologic oncology·2011
Same journal

Updates in management of cardiorenal syndrome.

Current opinion in nephrology and hypertension·2026
Same journal

Sex differences in renal acid-base regulation.

Current opinion in nephrology and hypertension·2026
Same journal

Primary prevention of chronic kidney disease in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitors.

Current opinion in nephrology and hypertension·2026
Same journal

Financial and policy challenges of delivering kidney replacement therapies in resource-limited settings.

Current opinion in nephrology and hypertension·2026
Same journal

The role of kir4.1/Kir5.1 in mediating the effect of angiotensin-II on Na-Cl-cotransporter.

Current opinion in nephrology and hypertension·2026
Same journal

Role of the calcium-sensing receptor in regulating calcium transport in the thick ascending limb.

Current opinion in nephrology and hypertension·2026
See all related articles

This review covers various renal tumors, including renal cell carcinoma, and associated genetic factors. While imaging techniques remain standard, surgical resection is the primary treatment for localized renal cell carcinoma.

Area of Science:

  • Urology
  • Oncology
  • Nephrology

Background:

  • Discusses a wide range of renal tumors, including benign and malignant types.
  • Highlights renal cell carcinoma (RCC) as the most common clinically relevant renal tumor, accounting for 85% of cases.
  • Reviews genetic associations, such as tumor suppressor gene loss on chromosome 3 in RCC development, and relevant syndromes like tuberous sclerosis and von Hippel-Lindau disease.

Purpose of the Study:

  • To provide a comprehensive overview of renal tumors and their management.
  • To review current understanding of the etiology and genetics of renal tumors.
  • To summarize the current state of renal tumor imaging and therapeutic options.

Main Methods:

  • Literature review of renal tumors, syndromes, imaging, and therapies.

Related Experiment Videos

  • Analysis of the prevalence and genetic basis of renal cell carcinoma.
  • Evaluation of current diagnostic imaging modalities (ultrasound, CT, MRI) and therapeutic strategies.
  • Main Results:

    • Renal cell carcinoma is the predominant renal tumor, linked to genetic factors like chromosome 3 abnormalities.
    • Standard imaging for renal masses includes ultrasound and computed tomography; MRI is mainly for staging.
    • Surgical resection remains the definitive treatment for localized renal cell carcinoma, with immunotherapy showing limited curative potential.

    Conclusions:

    • Current understanding of renal tumors involves a spectrum of neoplastic entities and associated genetic predispositions.
    • Despite advances in imaging sensitivity, established modalities and surgical intervention remain central to renal tumor management.
    • While immunotherapy offers some response, it is not a frequent cure for renal cell carcinoma, underscoring the importance of early detection and surgical treatment.